How Medtronic, Inc. (MDT) Overcame Obamacare to Hit Multi-Year Highs

Page 1 of 2

Obamacare has affected many companies throughout the health-care industry, but medical-device makers have taken a particularly large hit. That’s because the law imposed a 2.3% excise tax on sales of medical devices, hitting both profitable and unprofitable companies alike. Yet even though it’s subject to the tax, Medtronic, Inc. (NYSE:MDT) has managed to overcome Obamacare’s headwinds as the stock has climbed to levels not seen since before the financial crisis. The simple reason: a dividend history that demonstrates Medtronic, Inc. (NYSE:MDT)’s ability to weather similar storms in the past without harming investors in the process.

Medtronic, Inc. (NYSE:MDT)

Medtronic is a member of the elite Dividend Aristocrats list, where you’ll only find companies that have managed to increase their payouts to investors annually for at least 25 years. That’s a tall order for most companies, and only a few dozen stocks qualify to be Dividend Aristocrats. Let’s take a closer look at Medtronic, Inc. (NYSE:MDT) to see whether it can continue to keep its dividends rising despite the Obamacare tax.

Dividend stats on Medtronic

Current Quarterly Dividend Per Share $0.28
Current Yield 2.1%
Number of Consecutive Years With Dividend Increases 36 years
Payout Ratio 31%
Last Increase July 2013

Source: Yahoo! Finance. Last increase refers to ex-dividend date.

How Medtronic has kept its dividend strong
Medtronic’s stock has rewarded investors both through lucrative dividends and with share-price appreciation. Combining the two yields a 30% total return for Medtronic, Inc. (NYSE:MDT) so far in 2013, with the stock having held up well even during the overall market’s weakness over the past couple of months.

Medtronic’s latest quarterly earnings report shows just how well the company has managed to do even in a tough environment for the industry. Medtronic, Inc. (NYSE:MDT) reported cardiac sales that were up 4% year-over-year, and even though that might seem weak, it’s much better than its peers have done recently. Boston Scientific Corporation (NYSE:BSX) saw sales in its cardiac rhythm unit drop 5%, with international pricing pressure weighing on its ability to grow revenue. St. Jude Medical, Inc. (NYSE:STJ) reported an even bigger drop of 8% in its cardiac rhythm sales, with pacemaker-related revenue falling 12%. Medtronic, Inc. (NYSE:MDT) has also done a good job of taking advantage of international markets, with sales abroad rising 7% and representing half of its overall revenue. That success is particularly striking given that both St. Jude Medical, Inc. (NYSE:STJ) and Boston Scientific Corporation (NYSE:BSX) have seen declines in their international sales.

But Medtronic hasn’t seen everything go right. Back in May, the company said it planned to cut 230 jobs in its spinal business, which has been experiencing falling sales due to factors like Europe’s economic weakness and rising competition. Spine-rival Stryker Corporation (NYSE:SYK) also saw a 4% drop in segment sales last year, and it has also responded to adverse conditions in the industry by laying off employees. Stryker Corporation (NYSE:SYK) also specifically cited the Obamacare tax as a primary reason for its cost-cutting measures.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!